MUKKA PROTEINS LIMITED (MUKKA) financials

MUKKA PROTEINS LIMITED (MUKKA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2003, Mukka ProteinsLtd is a manufacturer and exporterof Fish Meal and Fish oil[1]

Market Cap: ₹837Cr.
Current Price: ₹27.9
Stock P/E: 13.8
ROE: 9.94%
ROCE: 11.1%
Book Value: ₹14.9
Dividend Yield: 0.00%
52W High / Low: ₹33.3/18.3

In Jun 2026, MUKKA PROTEINS LIMITED (MUKKA) reported sales ₹406 Cr and net profit ₹19 Cr.

Annual TTM: sales ₹1,499 Cr, net profit ₹61 Cr.

Shareholding: Promoters 73.33% (Sep 2026), FIIs 1.70% (Sep 2026), DIIs 0.20% (Sep 2026), Public 24.77% (Sep 2026), No. of Shareholders 1,24,299% (Sep 2026).

MUKKA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	126	287	325	136	222	558	313	406
Expenses	118	250	302	126	209	526	284	364
Operating Profit	8	37	23	10	14	33	29	42
OPM %	7%	13%	7%	8%	6%	6%	9%	10%
Other Income	3	7	4	3	6	7	14	2
Interest	8	10	9	10	12	14	14	15
Depreciation	2	1	1	1	2	2	3	2
Profit before tax	2	32	17	2	6	25	27	28
Tax %	-27%	21%	23%	37%	38%	24%	29%	29%
Net Profit	2	25	13	1	4	19	19	19
EPS in Rs	0.07	0.84	0.44	0.04	0.12	0.63	0.63	0.65
Raw PDF	—	—	—	—	—	—	—	—

MUKKA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	546	536	693	1,066	1,269	887	1,229	1,499
Expenses	526	529	660	1,000	1,187	811	1,143	1,382
Operating Profit	20	7	33	66	81	76	86	117
OPM %	3.7%	1.3%	4.7%	6%	6%	9%	7%	8%
Other Income	8	9	8	9	20	17	29	29
Interest	7	7	8	15	24	34	50	54
Depreciation	3	3	4	4	6	6	7	8
Profit before tax	19	6	28	55	72	53	59	84
Tax %	32%	24%	30%	28%	12%	21%	28%	—
Net Profit	13	5	20	39	63	42	42	61
EPS in Rs	—	—	0.90	1.79	2.09	1.39	1.41	2.03
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

MUKKA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	6	6	22	22	30	30	30
Reserves	40	52	57	60	100	335	374	417
Borrowings	81	112	126	162	238	332	418	682
Other Liabilities	70	88	99	84	141	154	152	239
Total Liabilities	197	257	288	329	500	851	974	1,368
Fixed Assets	44	46	49	50	52	60	60	88
CWIP	0	1	0	0	0	0	4	1
Investments	10	7	12	21	24	34	44	71
Other Assets	143	204	228	259	424	757	867	1,208
Total Assets	197	257	288	329	500	851	974	1,368

MUKKA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-22	-24	-2	-15	-47	-141	-132	-161
Cash from Investing Activity	-19	2	-5	-7	1	-46	-18	-43
Cash from Financing Activity	31	23	8	27	61	258	60	205
Net Cash Flow	-10	0	0	5	15	71	-91	2
Free Cash Flow	-35	-30	-7	-17	-50	-154	-142	-184
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-69%	-91%	29%	-40%	-58%	-146%	-170%	-172%

MUKKA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%	73.33%
FIIs	2.63%	2.63%	2.08%	1.70%	1.70%	1.70%	1.73%	1.70%
DIIs	1.98%	1.98%	1.87%	1.66%	0.17%	0.00%	0.00%	0.20%
Public	22.06%	22.05%	22.71%	23.31%	24.80%	24.97%	24.93%	24.77%
No. of Shareholders	1,46,062	1,47,308	1,45,343	1,41,649	1,37,920	1,32,098	1,27,922	1,24,299

MUKKA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	22	36	18	28	37	41	64	52
Inventory Days	94	68	108	88	87	135	274	280
Days Payable	59	58	59	44	49	43	69	75
Cash Conversion Cycle	57	47	67	72	75	133	269	256
Working Capital Days	9	10	6	6	10	43	105	63
ROCE %	—	15%	6%	16%	23%	18%	11%	11%

MUKKAUpdated 18 Oct 2026, 4:13

Mukka Proteins Limited

MUKKAUpdated 18 Oct 2026, 4:13

Market Cap

₹837Cr.

Current Price

₹27.9

High / Low

₹33.3/18.3

Stock P/E

13.8

ROE9.94%

ROCE11.1%

Book Value₹14.9

Face Value₹1.00

Dividend Yield0.00%

About

Incorporated in 2003, Mukka ProteinsLtd is a manufacturer and exporterof Fish Meal and Fish oil[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	239	5	228	3	1	8	43	4	0.2
Sep 2023	315	6	279	4	1	33	18	27	1.23
Dec 2023	484	5	472	8	1	13	31	9	0.41
Mar 2024	231	7	209	5	1	18	-25	22	0.74
Jun 2024	148	7	140	3	2	2	38	1	0.04
Sep 2024	126	8	118	3	2	2	-27	2	0.07
Dec 2024	287	10	250	7	1	32	21	25	0.84
Mar 2025	325	9	302	4	1	17	23	13	0.44
Jun 2025	136	10	126	3	1	2	37	1	0.04
Sep 2025	222	12	209	6	2	6	38	4	0.12
Dec 2025	558	14	526	7	2	25	24	19	0.63
Mar 2026	313	14	284	14	3	27	29	19	0.63
Jun 2026	406	15	364	2	2	28	29	19	0.65

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2019	407	4	383	2	2	21	25	15	—
Mar 2020	546	7	526	8	3	19	32	13	—
Mar 2021	536	7	529	9	3	6	24	5	—
Mar 2022	693	8	660	8	4	28	30	20	0.9
Mar 2023	1066	15	1000	9	4	55	28	39	1.79
Mar 2024	1269	24	1187	20	6	72	12	63	2.09
Mar 2025	887	34	811	17	6	53	21	42	1.39
Mar 2026	1229	50	1143	29	7	59	28	42	1.41
TTM	1499	54	1382	29	8	84	—	61	2.03

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	73.33%
FIIs	1.7%
DIIs	0.2%
Public	24.77%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Mar 2024	73.33%	6.46%	2%	18.21%
Jun 2024	73.33%	5.08%	2.5%	19.09%
Sep 2024	73.33%	2.81%	2%	21.84%
Dec 2024	73.33%	2.63%	1.98%	22.06%
Mar 2025	73.33%	2.63%	1.98%	22.05%
Jun 2025	73.33%	2.08%	1.87%	22.71%
Sep 2025	73.33%	1.7%	1.66%	23.31%
Dec 2025	73.33%	1.7%	0.17%	24.8%
Mar 2026	73.33%	1.7%	0%	24.97%
Jun 2026	73.33%	1.73%	0%	24.93%
Sep 2026	73.33%	1.7%	0.2%	24.77%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2019	6	40	81	70	197	44	0	10	143	197
Mar 2020	6	52	112	88	257	46	1	7	204	257
Mar 2021	6	57	126	99	288	49	0	12	228	288
Mar 2022	22	60	162	84	329	50	0	21	259	329
Mar 2023	22	100	238	141	500	52	0	24	424	500
Mar 2024	30	335	332	154	851	60	0	34	757	851
Mar 2025	30	374	418	152	974	60	4	44	867	974
Mar 2026	30	417	682	239	1368	88	1	71	1208	1368

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2019	-22	-19	31	-10
Mar 2020	-24	2	23	0
Mar 2021	-2	-5	8	0
Mar 2022	-15	-7	27	5
Mar 2023	-47	1	61	15
Mar 2024	-141	-46	258	71
Mar 2025	-132	-18	60	-91
Mar 2026	-161	-43	205	2

Key ratios

Historical financial ratios

Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	22	36	18	28	37	41	64	52
Inventory Days	94	68	108	88	87	135	274	280
Days Payable	59	58	59	44	49	43	69	75
Cash Conversion Cycle	57	47	67	72	75	133	269	256
Working Capital Days	9	10	6	6	10	43	105	63
ROCE %	—	15%	6%	16%	23%	18%	11%	11%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of MUKKA PROTEINS LIMITED (MUKKA)?

The reported market capitalisation for MUKKA PROTEINS LIMITED (MUKKA) is ₹837Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MUKKA?

The current price shown for MUKKA PROTEINS LIMITED (MUKKA) on Fincrux is ₹27.9 with a 52-week high/low of ₹33.3/18.3.

What is the P/E ratio of MUKKA PROTEINS LIMITED (MUKKA)?

The stock P/E for MUKKA PROTEINS LIMITED (MUKKA) is 13.8 on Fincrux, with ROE at 9.94% and ROCE at 11.1%.

What were MUKKA latest quarterly results?

For Jun 2026, MUKKA PROTEINS LIMITED (MUKKA) reported sales ₹406 Cr and net profit ₹19 Cr (figures in ₹ crore unless noted).

What are MUKKA annual sales and net profit?

For TTM, MUKKA PROTEINS LIMITED (MUKKA) shows sales of ₹1,499 Cr and net profit of ₹61 Cr on the Fincrux profit & loss statement.

Who owns MUKKA PROTEINS LIMITED (MUKKA)?

Latest shareholding for MUKKA PROTEINS LIMITED (MUKKA) on Fincrux: Promoters 73.33% (Sep 2026), FIIs 1.70% (Sep 2026), DIIs 0.20% (Sep 2026), Public 24.77% (Sep 2026), No. of Shareholders 1,24,299% (Sep 2026).

Where can I find MUKKA PROTEINS LIMITED (MUKKA) financials?

MUKKA PROTEINS LIMITED (MUKKA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MUKKA balance sheet and cash flow?

Yes. The MUKKA PROTEINS LIMITED (MUKKA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 4:13